GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
111 hedge funds and large institutions have $824M invested in Genomic Health, Inc. in 2013 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 39 increasing their positions, 38 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
19% less call options, than puts
Call options by funds: $992K | Put options by funds: $1.23M
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Holders
111
Holding in Top 10
1
Calls
$992K
Puts
$1.23M
Top Buyers
| 1 | +$9.16M | |
| 2 | +$3.4M | |
| 3 | +$3.24M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$2.04M |
| 5 |
CCMH
Cornerstone Capital Management Holdings
New York
|
+$1.2M |
Top Sellers
| 1 | -$4.85M | |
| 2 | -$3.95M | |
| 3 | -$3.02M | |
| 4 |
Two Sigma Investments
New York
|
-$2.85M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$2.29M |